Warsaw, Poland

Piotr Krzeczynski

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bio Research Project Psa. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Piotr Krzeczynski. Retrieved from https://idiyas.com/inventor/piotr-krzeczynski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Piotr Krzeczynski: Innovator in Medical Chemistry

Introduction

Piotr Krzeczynski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of medical chemistry, particularly in the development of innovative compounds that target specific biological pathways. His work has implications for the treatment of diseases associated with immune system dysregulation.

Latest Patents

Krzeczynski holds a patent for a 7-aminocephalosporanic acid derivative, specifically Cefazolin, which acts as an inhibitor of IL-15 and IL-2 activity. This invention is crucial for the prevention and treatment of diseases related to the overproduction of these interleukins. His patent portfolio includes 1 patent that showcases his expertise in this specialized area.

Career Highlights

Throughout his career, Piotr has worked with various organizations, including Bio Research Project PSA and Warszawski Uniwersytet Medyczny. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Barbara Zyzynska-Granica and Bartosz Trzaskowski. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Piotr Krzeczynski's contributions to medical chemistry and his innovative patent demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…